Menu Search
Equities

Siloam International Hospitals Tbk PT

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2LS:FRA

Siloam International Hospitals Tbk PT

Actions
  • Price (EUR)0.1270
  • Today's Change0.00 / 0.00%
  • Shares traded2.07k
  • 1 Year change-23.03%
  • Beta0.2344
Data delayed at least 15 minutes, as of Feb 12 2026 07:20 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PT Siloam International Hospitals Tbk (Siloam Hospitals) is an Indonesia-based healthcare provider. The Company's principal activity is engaging in healthcare provision, including setting up and managing hospitals. The operations of hospital units of the Company and subsidiaries (the Group) are in several cities on the island of Sumatra, Java, Bali, Kalimantan, Nusa Tenggara Timur, Nusa Tenggara Barat, Kuta, Nusa Dua and others. It has a hospital network that provides a range of specialized health services, including transplantation, gamma knife surgery, and brainstem surgery. It has more than 41 hospital branches and 25 clinics equipped with complete facilities and professional medical staff. It also offers specialists and sub-specialists to treat various types of diseases for people who need special medical care. It provides laboratory and radiology facilities. The Company provides medical check-up services for people who wish to maintain their health as a preventive action.

  • Revenue in IDR (TTM)12.51tn
  • Net income in IDR1.03tn
  • Incorporated1996
  • Employees15.09k
  • Location
    Siloam International Hospitals Tbk PTSiloam Hospitals Lt. 5Jl. Siloam No. 6, Lippo VillageTANGERANG 15810IndonesiaIDN
  • Phone+62 2 125668000
  • Fax+62 215460075
  • Websitehttps://www.siloamhospitals.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.